Reversal of multidrug resistance by surfactants.

Autor: Woodcock, DM, Linsenmeyer, ME, Chojnowski, G, Kriegler, AB, Nink, V, Webster, LK, Sawyer, WH, Woodcock, D M, Linsenmeyer, M E, Kriegler, A B, Webster, L K, Sawyer, W H

Publikováno v: British Journal of Cancer; Jul1992, Vol. 66 Issue 1, p62-68, 7p

Asymmetric methylation in the hypermethylated CpG promoter region of the human L1 retrotransposon.

Autor: Woodcock, D M, Lawler, C B, Linsenmeyer, M E, Doherty, J P, Warren, W D

Publikováno v: Journal of Biological Chemistry; March 1997, Vol. 272 Issue: 12 p7810-6, 7p

Phase I trial of cremophor EL with bolus doxorubicin.

Autor: Millward MJ; Division of Hematology and Medical Oncology, Peter MacCallum Cancer Institute, Melbourne, Australia. michaelm@canc.rpa.cs.nsw.gov.au, Webster LK, Rischin D, Stokes KH, Toner GC, Bishop JF, Olver IN, Linahan BM, Linsenmeyer ME, Woodcock DM

Publikováno v: Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 1998 Oct; Vol. 4 (10), pp. 2321-9.

A sizing artifact of DNA restriction fragments with unusually long single-stranded termini.

Autor: Woodcock DM; Peter MacCallum Cancer Institute, Melbourne, Victoria, Australia., Crowther PJ, Doherty JP, Linsenmeyer ME, Krüger DH

Publikováno v: Gene [Gene] 1991 Jun 15; Vol. 102 (1), pp. 79-81.

Effects of mcr restriction of methylated CpG islands of the L1 transposons during packaging and plating stages of mammalian genomic library construction.

Autor: Doherty JP; Molecular Genetics, Peter MacCallum Cancer Institute, Melbourne, Victoria, Australia., Graham MW, Linsenmeyer ME, Crowther PJ, Williamson M, Woodcock DM

Publikováno v: Gene [Gene] 1991 Feb 01; Vol. 98 (1), pp. 77-82.